Multiple Sclerosis Information
View Article  Importance of Early Treatment
Emphasis on the reduction of relapses as early as possible is important because you may not always recover your previous level of functioning after a relapse. Quite often, irreversible   more »
View Article  Tysabri - Incidence Of PML Lower
The risk of developing progressive multifocal leukoencephalopathy (PML), a viral brain infection, in patients with multiple sclerosis (MS) taking the drug natalizumab (Tysabri) appears to be much lower - and the infection   more »
View Article  Avonex – 10 Year Study Follow-up
with MRI findings. The CHAMPIONS ten-year follow up showed that patients treated immediately after their first episode had significantly less chance of experiencing a second attack versus those patients with delayed treatment. These results at ten years also indicate that 80 percent   more »
View Article  Copaxone Study – possible protective effect on brain tissue
New data presented today provided evidence that long-term treatment with COPAXONE® (glatiramer acetate injection) may offer sustained protection from neuronal/axonal injury. This protective effect was reflected biologically by a significant   more »